Zobrazeno 1 - 10
of 119
pro vyhledávání: '"Qi-fa Liu"'
Autor:
Yu Wang, Qi-Fa Liu, De-Pei Wu, Zheng-Li Xu, Ting-Ting Han, Yu-Qian Sun, Fen Huang, Zhi-Ping Fan, Na Xu, Feng Chen, Ye Zhao, Yuan Kong, Xiao-Dong Mo, Lan-Ping Xu, Xiao-Hui Zhang, Kai-Yan Liu, Xiao-Jun Huang
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-12 (2024)
Abstract Background There is an urgent unmet need for effective initial treatment for acute graft-versus-host disease (aGVHD) adding to the standard first-line therapy with corticosteroids after allogeneic haematopoietic stem cell transplantation (al
Externí odkaz:
https://doaj.org/article/fadebd47410447edb47679dca8895cf5
Autor:
Wei‐Ran Lv, Ya Zhou, Jun Xu, Zhi‐Ping Fan, Fen Huang, Na Xu, Li Xuan, Peng‐Cheng Shi, Hui Liu, Zhi‐Xiang Wang, Jing Sun, Qi‐Fa Liu
Publikováno v:
Cancer Medicine, Vol 10, Iss 23, Pp 8497-8506 (2021)
Abstract Background Secondary poor graft function (sPGF) is a serious complication after allogeneic hematopoietic stem cell transplantation (allo‐HSCT) related to poor outcome. We aimed to retrospectively evaluate the morbidity and hazard elements
Externí odkaz:
https://doaj.org/article/5476aeff76f8453bb3b98e200d363d32
Autor:
Xiao-hui Zhang, Jing Chen, Ming-Zhe Han, He Huang, Er-lie Jiang, Ming Jiang, Yong-rong Lai, Dai-hong Liu, Qi-Fa Liu, Ting Liu, Han-yun Ren, Yong-Ping Song, Zi-min Sun, Xiao-wen Tang, Jian-min Wang, De-pei Wu, Lan-ping Xu, Xi Zhang, Dao-bin Zhou, Xiao-jun Huang
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-20 (2021)
Abstract The consensus recommendations in 2018 from The Chinese Society of Hematology (CSH) on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation (allo-HSCT) facilitated the standardization o
Externí odkaz:
https://doaj.org/article/0888f470080e4c5f9d96fc5f09be3e84
Autor:
Zheng-Li Xu, Lan-Ping Xu, De-Pei Wu, Shun-Qing Wang, Xi Zhang, Rui Xi, Su-Jun Gao, Ling-Hui Xia, Jian-Min Yang, Ming Jiang, Xin Wang, Qi-Fa Liu, Jia Chen, Ming Zhou, Xiao-Jun Huang
Publikováno v:
Haematologica, Vol 107, Iss 12 (2022)
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains a curative option for severe aplastic anemia (SAA), and transplantation from identical sibling donors (ISD) has been recommended as a first-line treatment. Haploidentical donor (H
Externí odkaz:
https://doaj.org/article/b32cd12f96dd495c9a95be3032d97948
Autor:
Han-zhou Qi, Yi-ling Ye, Yuan Suo, Hong Qu, Hai-yan Zhang, Kai-bo Yang, Zhi-ping Fan, Fen Huang, Li Xuan, Yan-qiu Chen, Hua Jin, Qi-fa Liu
Publikováno v:
Cell Death and Disease, Vol 12, Iss 4, Pp 1-13 (2021)
Abstract Chronic graft-versus-host disease (cGVHD) is the main cause of non-relapse mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Mesenchymal stem cells (MSCs) in bone marrow (BM) remain unclear in the pathophysiolog
Externí odkaz:
https://doaj.org/article/2c6f9cfa8e8a49e893d83817e91f53f7
Autor:
Yu Wang, De-Pei Wu, Qi-Fa Liu, Lan-Ping Xu, Kai-Yan Liu, Xiao-Hui Zhang, Wen-Jing Yu, Yang Xu, Fen Huang, Xiao-Jun Huang
Publikováno v:
Journal of Hematology & Oncology, Vol 12, Iss 1, Pp 1-9 (2019)
Abstract Background Low-dose post-transplant cyclophosphamide (PTCy) in conjunction with anti-thymocyte globulin (ATG) appears as a potentially effective graft-versus-host disease (GVHD) prevention strategy in haploidentical hematopoietic cell transp
Externí odkaz:
https://doaj.org/article/6dabc0373653457a8e20be2c34558e88
Autor:
Cong-Meng Lin, Yan-Ling Zeng, Min Xiao, Xu-Qiao Mei, Lv-Ying Shen, Meng-Xian Guo, Zhe-Yao Lin, Qi-Fa Liu, Tin Yang
Publikováno v:
Cellular Physiology and Biochemistry, Vol 42, Iss 4, Pp 1458-1468 (2017)
Background: T-cell acute lymphoblastic leukemia (T-ALL) is a malignant hematological disease and is often accompanied by a variety of genetic abnormalities. Hence, our study aims to investigate the relationship between MMP-2 -1306C>T and MMP-9 -1562C
Externí odkaz:
https://doaj.org/article/d634ea9b856b49e8b23723bc937b4910
Autor:
Lan-Ping Xu, Song Jin, Shun-Qing Wang, Ling-Hui Xia, Hai Bai, Su-Jun Gao, Qi-Fa Liu, Jian-Min Wang, Xin Wang, Ming Jiang, Xi Zhang, De-Pei Wu, Xiao-Jun Huang
Publikováno v:
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-10 (2017)
Abstract Background Haploidentical donor (HID) hematopoietic stem cell transplantation (HSCT) is an alternative treatment method for severe aplastic anemia (SAA) patients lacking suitable identical donors and those who are refractory to immunosuppres
Externí odkaz:
https://doaj.org/article/dcef0791e73246cbb981fadf7d6eb50b
Autor:
Na Xu, Yu-ling Li, Xuan Li, Xuan Zhou, Rui Cao, Huan Li, Lin Li, Zi-yuan Lu, Ji-xian Huang, Zhi-ping Fan, Fen Huang, Hong-sheng Zhou, Song Zhang, Zhi Liu, Hong-qian Zhu, Qi-fa Liu, Xiao-li Liu
Publikováno v:
Journal of Hematology & Oncology, Vol 9, Iss 1, Pp 1-8 (2016)
Abstract Background Frequency relapses are common in Philadelphia chromosome-positive (Ph-positive) acute lymphoblastic leukemia (ALL) following tyrosine kinase inhibitors (TKIs). CDKN2A/B is believed to contribute to this chemotherapy resistance. Me
Externí odkaz:
https://doaj.org/article/b515c800ff08475c9128b8b6d762c3cf
Autor:
Han-zhou Qi, Jun Xu, Qian-qian Yang, Ren Lin, Zhi-xiang Wang, Ke Zhao, Qiang Wang, Xuan Zhou, Zhi-ping Fan, Fen Huang, Na Xu, Li Xuan, Hua Jin, Jing Sun, Robert Peter Gale, Hong-sheng Zhou, Qi-fa Liu
Publikováno v:
Bone Marrow Transplantation. 57:1704-1711
The optimal chemotherapy regimen pre-transplantation for adult T-cell acute lymphoblastic leukemia (T-ALL) patients remains unknown. Here, we compared the transplant outcomes in 127 subjects receiving pediatric- (N = 57) or adult-type (N = 70) regime